Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.
Fetuin-A, a circulating glycoprotein synthesized in the liver, is involved in insulin resistance and type 2 diabetes. However, regulation of fetuin-A synthesis has remained obscure. We previously reported that pioglitazone treatment significantly reduced serum fetuin-A levels in patients with type 2...
Main Authors: | Akinobu Ochi, Katsuhito Mori, Masanori Emoto, Shinya Nakatani, Tomoaki Morioka, Koka Motoyama, Shinya Fukumoto, Yasuo Imanishi, Hidenori Koyama, Eiji Ishimura, Masaaki Inaba |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3923806?pdf=render |
Similar Items
-
Effects of fetuin-A-containing calciprotein particles on posttranslational modifications of fetuin-A in HepG2 cells
by: Hideki Uedono, et al.
Published: (2021-04-01) -
Correlation between fetuin-A and matrix Gla protein levels in human serum
by: Katsuhito Mori, et al.
Published: (2010-07-01) -
Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes
by: Saori Maruo, et al.
Published: (2018-03-01) -
The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes
by: Reina Kawarabayashi, et al.
Published: (2017-01-01) -
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
by: Mori Katsuhito, et al.
Published: (2012-12-01)